Case Study: Extension of a Systematic Data-Based Reinforcement System to Increase Independence in Public-School Inclusion Settings to a Student with Down Syndrome and Intellectual Disability

2018 ◽  
Vol 41 (3) ◽  
pp. 345-355
Author(s):  
Audrey Gifford ◽  
Caroline C. Redpath ◽  
Karen M. Lionello-DeNolf
2015 ◽  
Vol 96 (5) ◽  
pp. 816-825 ◽  
Author(s):  
Marcello Niceta ◽  
Emilia Stellacci ◽  
Karen W. Gripp ◽  
Giuseppe Zampino ◽  
Maria Kousi ◽  
...  

Author(s):  
Anna J. Moyer ◽  
Roger H. Reeves

Is intellectual disability a treatable feature of persons with Down syndrome? Researchers have made tremendous progress in the last 30 years, from creating the first mouse model of Down syndrome to completing the first major clinical trial for cognitive impairment in people with Down syndrome. Until recently, normalizing brain development and function seemed too lofty a goal, and indeed, even proposing a candidate therapy requires answering a number of difficult questions. How does trisomy 21, a molecular diagnosis, cause the clinical phenotypes of Down syndrome? When, where, and how do trisomic genes act to disrupt normal development and which genes are involved with which outcomes? Which brain regions and behaviors are most impaired? Is there an early developmental window of time during which treatments are most effective? This article discusses how animal models such as laboratory mice can be used to understand intellectual disability and to develop new treatments for cognitive impairment.


2015 ◽  
Vol 16 (3) ◽  
pp. 291-307 ◽  
Author(s):  
Nicole Reinders ◽  
Pamela J. Bryden ◽  
Paula C. Fletcher

NHSA Dialog ◽  
1999 ◽  
Vol 2 (1) ◽  
pp. 116-119
Author(s):  
M. Jerry Cline ◽  
Frances Bridges-Cline

Sign in / Sign up

Export Citation Format

Share Document